U.S. market Open. Closes in 5 minutes

QLGN | Qualigen Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-03-312019-12-312018-12-312017-12-31
RevenueN/A4.98M5.65M4.31M5.56MN/A5.80MN/A
Cost of Revenue4.50K4.30M4.33M7.19M3.98M10.84T5.42M7.90M
Gross Profit-4.50K680.80K1.32M-2.88M1.58M-10.84T378.39K-7.90M
Operating Expenses11.30M18.62M23.98M17.40M3.08M10.70T1.42M7.65M
Selling, General & Admin6.09M11.79M12.27M8.42M1.88M4.57T1.43M4.78M
Research & Development5.21M6.84M11.72M3.55M1.21M6.13T1.32M2.87M
Other Operating Expenses-5.21M1.12K5.45KN/A2.79KN/AN/AN/A
Operating Income-11.30M-17.94M-22.66M-11.30M-1.50M-21.54T-1.06M-15.55M
Other Expenses / Income-1.17M-3.36M4.77M-9.12M2.79K11.41T-140.55K7.69M
Before Tax Income-12.48M-21.30M-17.89M-20.42M-1.78M-10.13T-1.20M-7.86M
Income Tax Expenses-4.79K-265.07K5.43K619.004.00KN/A4.62KN/A
Net Income-12.81M-21.03M-17.90M-20.42M-1.79M-10.13T-1.20M-7.86M
Interest Expenses1.52M26.65K-42.69KN/A283.10KN/AN/AN/A
Basic Shares Outstanding5.07M3.84M2.93M723.72K627.00K9.57T560.22K22.15M
Diluted Shares Outstanding5.07M3.84M2.93M723.72K627.00K9.57T560.22K22.15M
EBITDA-11.30M-14.23M-27.05M-11.16M-1.28M-21.54T-717.86K-15.55M
EBITDA Margin0.00%-285.64%-478.41%-259.27%-23.10%0.00%-12.37%0.00%
EBIT-11.30M-21.27M-17.93M-20.42M-1.50M-10.13T-1.20M-7.86M
EBIT Margin0.00%-426.87%-317.21%-474.15%-27.00%0.00%-20.61%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312020-03-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙